Pet Healthcare in China industry profile provides top-line qualitative and quantitative summary information including: market size (value 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The Chinese Pet healthcare market recorded revenues of $448 million in 2023, representing a compound annual growth rate (CAGR) of 5.1% between 2018 and 2023.
- Market consumption volume increased with a CAGR of 2.5% between 2018 and 2023, to reach a total of 85.3 million units in 2023.
- The performance of the market is forecast to decelerate, with an anticipated CAGR of 3% over 2023-28, which is expected to drive the market to a value of $519.4 million by the end of 2028.
Scope
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pet healthcare market in China
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pet healthcare market in China
- Leading company profiles reveal details of key pet healthcare market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the China pet healthcare market with five year forecasts
Reasons to Buy
- What was the size of the China pet healthcare market by value in 2023?
- What will be the size of the China pet healthcare market in 2028?
- What factors are affecting the strength of competition in the China pet healthcare market?
- How has the market performed over the last five years?
- How large is China’s pet healthcare market in relation to its regional counterparts?
Table of Contents
1 Executive Summary
2 Market Overview
3 Market Data
4 Market Segmentation
5 Market Outlook
6 Five Forces Analysis
7 Competitive Landscape
8 Company Profiles
9 Macroeconomic Indicators
10 Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Zoetis Inc
- Boehringer Ingelheim GmbH
